These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Plasma concentrations of remoxipride and haloperidol in relation to prolactin and short-term therapeutic outcome in schizophrenic patients. Lahdelma RL; Appelberg B; Kuoppasalmi K; Katila H; Rimón R Eur Neuropsychopharmacol; 1991 Dec; 1(4):535-40. PubMed ID: 1688013 [TBL] [Abstract][Full Text] [Related]
12. Amisulpride: efficacy in the management of chronic patients with predominant negative symptoms of schizophrenia. Möller HJ Eur Arch Psychiatry Clin Neurosci; 2001 Oct; 251(5):217-24. PubMed ID: 11829208 [TBL] [Abstract][Full Text] [Related]
13. Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations. Alfredsson G; Härnryd C; Wiesel FA Psychopharmacology (Berl); 1985; 85(1):8-13. PubMed ID: 3920702 [TBL] [Abstract][Full Text] [Related]
14. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia. Möller HJ; Riedel M; Jäger M; Wickelmaier F; Maier W; Kühn KU; Buchkremer G; Heuser I; Klosterkötter J; Gastpar M; Braus DF; Schlösser R; Schneider F; Ohmann C; Riesbeck M; Gaebel W Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670 [TBL] [Abstract][Full Text] [Related]
16. [Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol]. Barnas C; Stuppäck CH; Miller C; Haring C; Sperner-Unterweger B; Fleischhacker WW Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():36-40. PubMed ID: 1683338 [TBL] [Abstract][Full Text] [Related]
17. Clinical profile of remoxipride--a combined analysis of a comparative double-blind multicentre trial programme. Lewander T; Westerbergh SE; Morrison D Acta Psychiatr Scand Suppl; 1990; 358():92-8. PubMed ID: 1978500 [TBL] [Abstract][Full Text] [Related]
18. Effects of sulpiride and chlorpromazine on depressive symptoms in schizophrenic patients--relationship to drug concentrations. Alfredsson G; Härnryd C; Wiesel FA Psychopharmacology (Berl); 1984; 84(2):237-41. PubMed ID: 6438683 [TBL] [Abstract][Full Text] [Related]
19. Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine. Alfredsson G; Bjerkenstedt L; Edman G; Härnryd C; Oxenstierna G; Sedvall G; Wiesel FA Acta Psychiatr Scand Suppl; 1984; 311():49-74. PubMed ID: 6199949 [TBL] [Abstract][Full Text] [Related]
20. Relationship of serum haloperidol levels to clinical response in schizophrenic patients. Magliozzi JR; Hollister LE; Arnold KV; Earle GM Am J Psychiatry; 1981 Mar; 138(3):365-7. PubMed ID: 7468835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]